Earnings calendar/IBIDF
Ibiden Co., Ltd./ADR (IBIDF)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Ibiden Co., Ltd./ADR has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q1 FY2027
Filed
Jun 30, 2026
Filing date on record
EPS (diluted)
$59.74
Est. $0.33 · +17888.6%
Revenue
$122.33B
Est. $714.8M · +17014.0%
Net income
$17.79B
As filed
EPS YoY
+39.3%
vs quarter ended 2025-06-30
Revenue YoY
+25.5%
vs quarter ended 2025-06-30
Next report
Oct 29, 2026
Scheduled · est. EPS $0.51
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$232.40
2025-09-30 through 2026-06-30
TTM revenue
$443.30B
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
100%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q1 FY2027 | 2026-06-30 | $59.74 | $122.33B | +39.3% | +25.5% | $0.33 | +17888.6% |
| 2026-03-31Q4 FY2026 | 2026-03-31 | $108.65 | $118.32B | +262.4% | +19.4% | $0.30 | +36116.7% |
| 2025-12-31Q3 FY2026 | 2025-12-31 | $32.01 | $103.23B | +118.8% | +16.3% | $0.24 | +13469.3% |
| 2025-09-30Q2 FY2026 | 2025-09-30 | $32.00 | $99.42B | -19.4% | +6.5% | $0.23 | +13788.9% |
| 2025-06-30Q1 FY2026 | 2025-06-30 | $42.88 | $97.46B | +44.9% | +10.5% | $0.23 | +18707.0% |
| 2025-03-31Q4 FY2025 | 2025-03-31 | $29.98 | $99.10B | +4.8% | +9.7% | $0.13 | +22820.5% |
| 2024-12-31Q3 FY2025 | 2024-12-31 | $14.63 | $88.75B | -78.5% | -4.1% | $0.16 | +9153.6% |
| 2024-09-30Q2 FY2025 | 2024-09-30 | $39.72 | $93.36B | -47.7% | +0.4% | $0.23 | +17072.5% |
| 2024-06-30Q1 FY2025 | 2024-06-30 | $29.59 | $88.22B | -43.3% | -6.7% | $0.16 | +17844.2% |
| 2024-03-31Q4 FY2024 | 2024-03-31 | $28.62 | $90.34B | -50.9% | -10.4% | $0.19 | +14907.9% |
| 2023-12-31Q3 FY2024 | 2023-12-31 | $68.03 | $92.53B | -22.4% | -10.3% | $0.26 | +26557.5% |
| 2023-09-30Q2 FY2024 | 2023-09-30 | $75.91 | $93.04B | -41.4% | -19.3% | $0.45 | +16958.4% |
| 2023-06-30Q1 FY2024 | 2023-06-30 | $52.18 | $94.60B | -46.9% | -3.8% | $0.27 | +19290.6% |
| 2023-03-31Q4 FY2023 | 2023-03-31 | $58.23 | $100.87B | +114.5% | -1.0% | $0.20 | +28899.0% |
| 2022-12-31Q3 FY2023 | 2022-12-31 | $87.67 | $103.10B | -19.4% | -0.3% | $0.73 | +11959.1% |
| 2022-09-30Q2 FY2023 | 2022-09-30 | $129.64 | $115.26B | +42.6% | +11.4% | $0.01 | +2057677.8% |
| 2022-06-30Q1 FY2023 | 2022-06-30 | $98.23 | $98.32B | +43.4% | +6.5% | $0.57 | +17163.6% |
| 2022-03-31Q4 FY2022 | 2022-03-31 | $27.15 | $101.90B | -11.8% | +8.8% | $0.60 | +4447.7% |
| 2021-12-31Q3 FY2022 | 2021-12-31 | $108.79 | $103.40B | +56.5% | +20.5% | $0.66 | +16333.5% |
| 2021-09-30Q2 FY2022 | 2021-09-30 | $90.89 | $103.50B | +79.2% | +30.7% | $77.81 | +16.8% |
| 2021-06-30Q1 FY2022 | 2021-06-30 | $68.51 | $92.33B | +108.3% | +42.4% | $56.92 | +20.4% |
| 2021-03-31Q4 FY2021 | 2021-03-31 | $30.79 | $93.68B | +36.7% | +18.4% | — | — |
| 2020-12-31Q3 FY2021 | 2020-12-31 | $69.53 | $85.79B | +126.7% | +18.2% | — | — |
| 2020-09-30Q2 FY2021 | 2020-09-30 | $50.73 | $79.16B | +613.5% | +11.4% | — | — |
| 2020-06-30Q1 FY2021 | 2020-06-30 | $32.89 | $64.83B | +58.3% | -11.6% | — | — |
| 2020-03-31Q4 FY2020 | 2020-03-31 | $22.52 | $79.09B | -22.1% | +3.2% | — | — |
| 2019-12-31Q3 FY2020 | 2019-12-31 | $30.67 | $72.55B | +168.6% | +3.3% | — | — |
| 2019-09-30Q2 FY2020 | 2019-09-30 | $7.11 | $71.05B | -64.8% | -1.8% | — | — |
| 2019-06-30Q1 FY2020 | 2019-06-30 | $20.78 | $73.30B | +7.9% | +2.0% | — | — |
| 2019-03-31Q4 FY2019 | 2019-03-31 | $28.92 | $76.62B | +23.6% | -11.3% | — | — |
| 2018-12-31Q3 FY2019 | 2018-12-31 | $-44.68 | $70.26B | -440.3% | -2.4% | — | — |
| 2018-09-30Q2 FY2019 | 2018-09-30 | $20.18 | $72.38B | -39.1% | -2.7% | — | — |
| 2018-06-30Q1 FY2019 | 2018-06-30 | $19.25 | $71.87B | +43.3% | +6.3% | — | — |
| 2018-03-31Q4 FY2018 | 2018-03-31 | $23.40 | $86.41B | +188.3% | +16.2% | — | — |
| 2017-12-31Q3 FY2018 | 2017-12-31 | $13.13 | $72.01B | +112.6% | +14.1% | — | — |
| 2017-09-30Q2 FY2018 | 2017-09-30 | $33.12 | $74.36B | +110.0% | +17.2% | — | — |
| 2017-06-30Q1 FY2018 | 2017-06-30 | $13.43 | $67.61B | — | — | — | — |
| 2017-03-31Q4 FY2017 | 2017-03-31 | $-26.50 | $74.35B | — | — | — | — |
| 2016-12-31Q3 FY2017 | 2016-12-31 | $-104.05 | $63.13B | — | — | — | — |
| 2016-09-30Q2 FY2017 | 2016-09-30 | $-329.80 | $63.47B | — | — | — | — |
Need IBIDF data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.